From the desk of Pituitary World News co-founder J D Faccinetti – In November 2019, we wrote an opinion piece on the current discussion about reclassifying and renaming pituitary adenomas to Pituitary Neuroendocrine Tumors or PitNETs. Well, the rumblings about this change and the arguments from the proponents and opponents to the reclassification are continuing. Read more and vote!
A young woman called me last year to make an appointment. She told me she had recently had endoscopic neurosurgery for craniopharyngioma. She was suffering from severe anxiety and depression. She hoped to find a mental health professional who would understand the critical link between the endocrine system and her mental health symptoms.
Today’s podcast focuses on an opportunity to learn about a group of rare diseases that share a common condition with pituitary disease. Histiocytosis or histiocytic disorders are a group of rare diseases that occur when there is an overproduction of white blood cells known as histiocytes that can lead to organ damage and tumor formation. DI impacts almost 50% of Histiocytosis patients and 35% of pituitary patients.
It’s always fascinating to listen to two of the recognized experts and leading clinicians in Cushing’s disease discuss their experiences with the disease and patients. In this Live Talk session, Pituitary World New’s innovative program for education and awareness, Dr. Kevin Yuen and Dr. Lewis Blevins bring an intimate, revealing look at their approaches to Cushing’s disease and syndrome.
An opinion editorial from J D Faccinetti, co-founder, on listening and interpreting without influencing – Progressive, innovative enterprises have been putting the voice of the consumer front and center in product and communications development since
Listen to Dr. Tamara Wexler, a nationally recognized neuroendocrinologist and expert in pituitary dysfunction after a brain injury. She joins Dr. Lewis Blevins in this eye-opening podcast.
I’m happy to welcome Leslie Edwin, president of Cushing’s Support and Research Foundation (CSRF), to our microphones. The CSRF is a leading Cushing’s disease and syndrome patient support organization.
A commentary from Lewis S. Blevins Jr. M.D. – Dr. Lewis Blevins reviews a recent article published by Mohyeldin and others from Stanford University in Scientific Reports.
Mental health and emotional wellness are essential topics for pituitary patients, their families, and friends. This on-demand session from last Thursday’s live-talk program focuses on the challenges and opportunities when considering these issues.
A commentary from Lewis S. Blevins Jr. M.D., PWN Co-founder – In my opinion, those of us who “profess” to be academics and champions of, as Robert Graham the designer includes on his apparel, “knowledge wisdom
Decisions made by doctors and their patients can be some of the most complicated, difficult decisions to make. This session focuses on the factors that influence medical decision-making, the impacts those decisions carry, and how the practical clinical aspects of these choices affect our everyday lives.
This study is available free. Just click on this link to download it. As a way of background, this is the second Phase 3 study for ISTURISA (osilodrostat). The first phase 3 study, LINC 3,